3,4-dihydroxyphenylacetic acid has been researched along with Heart Failure in 5 studies
3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA.
(3,4-dihydroxyphenyl)acetic acid : A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine.
dihydroxyphenylacetic acid : A dihydroxy monocarboxylic acid consisting of phenylacetic acid having two phenolic hydroxy substituents.
Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mamalyga, ML | 1 |
| Mamalyga, LM | 1 |
| Mercuro, G | 1 |
| Rossetti, ZL | 2 |
| Rivano, CA | 2 |
| Cherchi, A | 2 |
| Gessa, GL | 1 |
| Soares-da-Silva, P | 2 |
| Pestana, M | 2 |
| Ferreira, A | 2 |
| Damasceno, A | 1 |
| Polónia, J | 1 |
| Cerqueira-Gomes, M | 2 |
| Bettencourt, P | 1 |
| Pimenta, J | 1 |
| Friões, F | 1 |
| Mercuro, GG | 1 |
| Tocco, L | 1 |
| Ruscazio, M | 1 |
| Sau, F | 1 |
| Fonzo, R | 1 |
1 review available for 3,4-dihydroxyphenylacetic acid and Heart Failure
| Article | Year |
|---|---|
Renal dopaminergic mechanisms in renal parenchymal diseases, hypertension, and heart failure.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Dopamine; Heart Failure; Hemodynamics; Humans; Hypertension | 2000 |
4 other studies available for 3,4-dihydroxyphenylacetic acid and Heart Failure
| Article | Year |
|---|---|
Effect of Progressive Heart Failure on Cerebral Hemodynamics and Monoamine Metabolism in CNS.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Basilar Artery; Brain; Brain Chemistry; Carotid Arteries; C | 2017 |
Marked increase of plasma 3,4-dihydroxyphenylacetic acid in congestive heart failure.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Heart Failure; Humans; Male; Middle Aged; Norepinephrine; Phen | 1984 |
The renal dopaminergic system, neurohumoral activation, and sodium handling in heart failure.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Aldosterone; Atrial Natriuretic Factor; Case-Control Studies; | 2002 |
[Plasma increase of dihydroxyphenylacetic acid, a dopamine metabolite, in cardiac decompensation].
Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; | 1985 |